Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Buy
53
ARCAY Quote, Financials, Valuation and Earnings
Last price:
$52.50
Seasonality move
:
7.51%
Day range:
$52.50 - $52.50
52-week range:
$28.86 - $75.99
Dividend yield:
2.16%
P/E ratio:
14.23x
P/S ratio:
0.88x
P/B ratio:
5.74x
Volume:
7
Avg. volume:
281
1-year change:
-10.03%
Market cap:
$4.7B
Revenue:
$5.4B
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Arcadis NV has -- downside to fair value with a price target of -- per share.
ARCAY vs. S&P 500
-
Over the past 5 trading days, Arcadis NV has overperformed the S&P 500 by 0.35% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Arcadis NV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Arcadis NV has grown year-over-year revenues for 15 quarters straight. In the most recent quarter Arcadis NV reported revenues of $1B.
Earnings Growth
-
Arcadis NV has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Arcadis NV reported earnings per share of --.
Enterprise value:
5B
EV / Invested capital:
--
Price / LTM sales:
0.88x
EV / EBIT:
12.22x
EV / Revenue:
0.93x
PEG ratio (5yr expected):
0.17x
EV / Free cash flow:
17.74x
Price / Operating cash flow:
16.74x
Enterprise value / EBITDA:
8.97x
Gross Profit (TTM):
$814.3M
Return On Assets:
6.14%
Net Income Margin (TTM):
4.8%
Return On Equity:
20.81%
Return On Invested Capital:
11.05%
Operating Margin:
11.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $4.2B | $5.4B | $5.4B | -- | $1B | |
| Gross Profit | $560.8M | $679.2M | $813.4M | -- | -- | |
| Operating Income | $282.1M | $301.2M | $420.8M | -- | -- | |
| EBITDA | $409M | $503.6M | $572.2M | -- | -- | |
| Diluted EPS | $1.61 | $1.80 | $2.92 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.7B | $1.6B | $2B | $2B | $2.3B | |
| Total Assets | $3.2B | $2.9B | $4.3B | $4.2B | $4.5B | |
| Current Liabilities | $1.4B | $1.3B | $1.8B | $1.6B | $1.8B | |
| Total Liabilities | $2.1B | $1.8B | $3.1B | $2.9B | $3.3B | |
| Total Equity | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2011-12-31 | 2012-12-31 | 2013-12-31 | 2012-12-31 | 2013-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $111M | $203.6M | $186.1M | $116.8M | $137.2M | |
| Cash From Investing | -$173.9M | -$152.4M | -$83.2M | -$22.6M | -$24.2M | |
| Cash From Financing | -$6.3M | -$10.1M | -$126.2M | -$43.2M | -$121.2M | |
| Free Cash Flow | $61.9M | $159M | $143.2M | $103M | $128.4M | |
ARCAY
Sector
Market Cap
$4.7B
$499.8M
Price % of 52-Week High
69.08%
83.21%
Dividend Yield
2.16%
0%
Shareholder Yield
3.67%
1.53%
1-Year Price Total Return
-10.03%
--
Beta (5-Year)
0.446
0.531
Dividend yield:
2.16%
Annualized payout:
$0.92
Payout ratio:
-37.79%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$51.12
200-day SMA
Buy
Level
$48.67
Bollinger Bands (100)
Buy
Level
41.65 - 53.17
Chaikin Money Flow
Sell
Level
-616K
20-day SMA
Buy
Level
$45.87
Relative Strength Index (RSI14)
Buy
Level
77.30
ADX Line
Buy
Level
27.41
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$43.54
MACD (12, 26)
Buy
Level
2.82
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
1.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.077)
Sell
CA Score
(Annual)
Level (-0.5217)
Buy
Beneish M-Score
(Annual)
Level (-2.6725)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.5905)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Arcadis NV is a design and consultancy firm, which engages in the provision of consultancy, design, engineering, and management services. It operates through the following segments: Places, Mobility, Resilience, and Intelligency. The company was founded in 1888 and is headquartered in Amsterdam, the Netherlands.
Stock Forecast FAQ
In the current month, ARCAY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ARCAY average analyst price target in the past 3 months is --.
-
Where Will Arcadis NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Arcadis NV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Arcadis NV?
Analysts are divided on their view about Arcadis NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Arcadis NV is a Sell and believe this share price will rise from its current level to --.
-
What Is Arcadis NV's Price Target?
The price target for Arcadis NV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ARCAY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Arcadis NV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ARCAY?
You can purchase shares of Arcadis NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Arcadis NV shares.
-
What Is The Arcadis NV Share Price Today?
Arcadis NV was last trading at $52.50 per share. This represents the most recent stock quote for Arcadis NV. Yesterday, Arcadis NV closed at $52.50 per share.
-
How To Buy Arcadis NV Stock Online?
In order to purchase Arcadis NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ARCAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARCAY
Sector
P/E ratio
14.23x
20.03x
PEG ratio
0.17x
0.18x
P/B ratio
5.74x
1.75x
Price / LTM sales
0.88x
0.87x
Growth Metrics
ARCAY
Sector
Revenue growth
28.69%
4.81%
Earnings growth
--
5.65%
Revenue (5-year growth)
6.81%
4.21%
Earnings forecast
--
$0.34
Profitability
ARCAY
Sector
Profitability FY 2024
$813.4M
$248.2M
Return on invested capital
11.05%
4.64%
Return on assets
6.14%
3.09%
Return on equity
20.81%
8.04%
Earnings Date
Last Earnings Date
Jul
31
Next Earnings Date
Feb
19
Estimated Next Earnings Date
Oct
30
Balance Sheet
ARCAY
Sector
Total cash
$368.2M
$136.8M
Short term investments
--
$31.8M
Total assets
$4.3B
$1.4B
Long term debt
--
$47.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is down 30.3% over the past day.
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 32.13% over the past day.
Sell
48
RVMD alert for Jan 27
Revolution Medicines, Inc. [RVMD] is up 2.3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
